Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001711456-17-000005
Filing Date
2017-10-27
Accepted
2017-10-27 20:27:31
Documents
1
Period of Report
2014-01-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 4575
  Complete submission text file 0001711456-17-000005.txt   6327
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Issuer) CIK: 0001534525 (see all company filings)

EIN.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 25 LITER KRASNOVO KURSANTA STREET ST. PETERSBURG 1Z 197110
Business Address 25 LITER KRASNOVO KURSANTA STREET ST. PETERSBURG 1Z 197110 79036888758
LLC Synbio (Reporting) CIK: 0001711456 (see all company filings)

State of Incorp.: 1Z | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37937 | Film No.: 171160545